Income Statement Zhuhai Rundu Pharmaceutical Co., Ltd.

Stocks

002923

CNE1000033G8

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 17/07/2026			5-day change	1st Jan Change
10.65 ^CNY	-9.97%		-0.19%	-12.35%

05-22	Zhuhai Rundu Pharmaceutical Wins China Approval for Pain Relief Drug	MT
05-19	China Grants Zhuhai Rundu Pharmaceutical Marketing Approval for Hypertension Drug	MT

9973c583b1e.anaj2jSgQDN4x99zt0tjYmMLsdhgp_-8etNVkcdu7Zo.PQfWnQ3JK3sLqporwC8JWzU9-a8q0MbtHp0cyYMrot1fHeSsf5ciakm0kg

Published financial data: ZHUHAI RUNDU PHARMACEUTICAL CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	1.19B	1.36B	1.28B	1.18B	1.16B
Other Revenues, Total	1.98M	9.01M	10.06M	5.53M	18.08M
Total Revenues	1.19B	1.37B	1.29B	1.18B	1.18B
Cost of Goods Sold, Total	479M	636M	685M	692M	765M
Gross Profit	711M	736M	607M	490M	412M
Selling General & Admin Expenses, Total	476M	460M	393M	310M	332M
Provision for Bad Debts	487K	2.56M	-728K	139K	1.17M
R&D Expenses	84.27M	92.34M	127M	129M	92.38M
Other Operating Expenses	12M	15.25M	15.46M	11.27M	12.62M
Other Operating Expenses, Total	573M	570M	535M	451M	438M
Operating Income	138M	166M	72.31M	39.52M	-26.57M
Interest Expense, Total	-1.77M	-6.97M	-16.12M	-15.78M	-13.11M
Interest And Investment Income	2.33M	1.48M	2.25M	1.33M	1.67M
Net Interest Expenses	559K	-5.49M	-13.86M	-14.45M	-11.44M
Currency Exchange Gains (Loss)	-1.34M	1.3M	1.76M	2.85M	-379K
Other Non Operating Income (Expenses)	-860K	-453K	-1.12M	-1.94M	-5.08M
EBT, Excl. Unusual Items	137M	161M	59.09M	25.98M	-43.46M
Restructuring Charges	-	-	-	-	-13.32M
Gain (Loss) On Sale Of Investments	-18.02K	-24.99K	-364K	13.48K	-12.07K
Gain (Loss) On Sale Of Assets	-	46.8K	152K	18.02M	628K
Asset Writedown	-228K	-326K	-148K	-433K	-16.78M
Insurance Settlements	-	-	-	-	-
Other Unusual Items	15.14M	19.86M	27.31M	-955K	13.36M
EBT, Incl. Unusual Items	152M	181M	86.04M	42.63M	-59.59M
Income Tax Expense	11.97M	25.46M	19.14M	2.74M	3.88M
Earnings From Continuing Operations	140M	155M	66.9M	39.88M	-63.47M
Net Income to Company	140M	155M	66.9M	39.88M	-63.47M
Net Income - (IS)	140M	155M	66.9M	39.88M	-63.47M
Net Income to Common Incl Extra Items	140M	155M	66.9M	39.88M	-63.47M
Net Income to Common Excl. Extra Items	140M	155M	66.9M	39.88M	-63.47M
Per Share Items
Net EPS - Basic	0.42	0.46	0.2	0.12	-0.19
Basic EPS - Continuing Operations	0.42	0.46	0.2	0.12	-0.19
Basic Weighted Average Shares Outstanding	335M	335M	334M	332M	334M
Net EPS - Diluted	0.42	0.46	0.2	0.12	-0.19
Diluted EPS - Continuing Operations	0.42	0.46	0.2	0.12	-0.19
Diluted Weighted Average Shares Outstanding	335M	335M	334M	332M	334M
Normalized Basic EPS	0.26	0.3	0.11	0.05	-0.08
Normalized Diluted EPS	0.26	0.3	0.11	0.05	-0.08
Dividend Per Share	0.22	0.25	0.2	0.15	-
Payout Ratio	59.13	57.68	153.04	212.36	-100.97
Supplemental Items
EBITDA	198M	235M	183M	173M	115M
EBITA	140M	168M	73.88M	41.15M	-25.14M
EBIT	138M	166M	72.31M	39.52M	-26.57M
EBITDAR	200M	237M	188M	178M	117M
Total Revenues (As Reported)	1.19B	1.37B	1.29B	1.18B	1.18B
Effective Tax Rate - (Ratio)	7.89	14.07	22.25	6.44	-6.52
Current Domestic Taxes	8.94M	27.08M	17.28M	3M	8.45M
Total Current Taxes	8.94M	27.08M	17.28M	3M	8.45M
Deferred Domestic Taxes	3.03M	-1.62M	1.87M	-260K	-4.57M
Total Deferred Taxes	3.03M	-1.62M	1.87M	-260K	-4.57M
Normalized Net Income	85.53M	101M	36.93M	16.24M	-27.16M
Interest Capitalized	6.14M	9.5M	-	3.06M	2.04M
Interest on Long-Term Debt	-	-	159K	383K	671K
Non-Cash Pension Expense	-	-	357K	1.88M	13.32M
Supplemental Operating Expense Items
Marketing Expenses	-	334M	255M	193M	202M
Selling and Marketing Expenses	417M	390M	315M	246M	260M
General and Administrative Expenses	59.19M	70.19M	77.88M	64.5M	71.7M
Research And Development Expense From Footnotes	92.14M	95.59M	129M	131M	94.12M
Net Rental Expense, Total	1.54M	1.56M	4.55M	4.56M	2.52M
Imputed Operating Lease Interest Expense	548K	545K	1.13M	1.28M	591K
Imputed Operating Lease Depreciation	994K	1.02M	3.42M	3.28M	1.93M
Maintenance & Repair Expenses, Total	16.15M	5.65M	3.4M	4.76M	2.7M
Stock-Based Comp., G&A Exp. (Total)	-6.7M	-	-	-	-
Total Stock-Based Compensation	-6.7M	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	250M	221M	214M	207M	256M
Short Term Investments	-	-	-	-	-
Trading Asset Securities, Total	86.77K	61.78K	52.23K	65.71K	53.63K
Total Cash And Short Term Investments	250M	221M	214M	207M	256M
Accounts Receivable, Total	160M	202M	212M	213M	198M
Other Receivables	3.09M	61.37M	3.95M	4.92M	2.61M
Total Receivables	163M	264M	216M	218M	201M
Inventory	336M	441M	415M	442M	395M
Other Current Assets, Total	59.13M	20.62M	21.3M	18.83M	4.83M
Total Current Assets	808M	946M	867M	886M	856M
Gross Property Plant And Equipment	1.23B	1.55B	1.68B	1.77B	1.78B
Accumulated Depreciation	-262M	-330M	-432M	-563M	-697M
Net Property Plant And Equipment	973M	1.22B	1.25B	1.21B	1.08B
Long-term Investments	500K	500K	500K	-	-
Other Intangibles, Total	69M	67.62M	66.05M	64.42M	63M
Deferred Tax Assets Long-Term	8.61M	10.23M	10.67M	10.35M	13.9M
Deferred Charges Long-Term	13.31M	12.81M	19.93M	13.66M	9.78M
Other Long-Term Assets, Total	37.31M	25.23M	14.27M	10.55M	3.42M
Total Assets	1.91B	2.29B	2.23B	2.19B	2.03B
Liabilities
Accounts Payable, Total	152M	213M	154M	223M	144M
Accrued Expenses, Total	164M	178M	116M	112M	115M
Short-term Borrowings	33M	62.94M	60.54M	25.04M	133M
Current Portion of Long-Term Debt	-	25.28M	68.82M	106M	86.69M
Current Portion of Leases	2.52M	1.75M	2.11M	2.22M	1.1M
Current Income Taxes Payable	137K	11.47M	2.26M	-	-
Unearned Revenue Current, Total	14.29M	46.68M	10.89M	12.46M	17.92M
Other Current Liabilities	56.11M	50.11M	31.93M	42.65M	38.02M
Total Current Liabilities	423M	590M	446M	524M	535M
Long-Term Debt	250M	377M	434M	362M	310M
Long-Term Leases	1.08M	975K	7.48M	5.56M	1.77M
Unearned Revenue Non Current	120M	121M	158M	147M	137M
Deferred Tax Liability Non Current	-	-	2.31M	1.73M	709K
Other Non Current Liabilities	3.6M	1.18M	1.07M	1.89M	5.58M
Total Liabilities	797M	1.09B	1.05B	1.04B	990M
Common Stock, Total	186M	239M	335M	335M	335M
Additional Paid In Capital	346M	279M	183M	183M	183M
Retained Earnings	594M	678M	661M	634M	520M
Treasury Stock	-13.86M	-	-	-	-
Comprehensive Income and Other	-	-	-55	380	-756
Total Common Equity	1.11B	1.2B	1.18B	1.15B	1.04B
Total Equity	1.11B	1.2B	1.18B	1.15B	1.04B
Total Liabilities And Equity	1.91B	2.29B	2.23B	2.19B	2.03B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	338M	335M	335M	335M	335M
ECS Total Common Shares Outstanding	338M	335M	335M	335M	335M
Book Value / Share	3.29	3.57	3.52	3.44	3.1
Tangible Book Value	1.04B	1.13B	1.11B	1.09B	975M
Tangible Book Value Per Share	3.09	3.37	3.32	3.25	2.91
Total Debt	287M	468M	573M	501M	532M
Net Debt	36.22M	247M	359M	294M	276M
Debt Equivalent Oper. Leases	12.34M	12.49M	36.37M	36.49M	20.13M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	63.76M	119M	112M	69.64M	69.41M
Inventories - Work In Process, Total	107M	128M	94.17M	67.61M	54.63M
Inventories - Finished Goods, Total	174M	232M	270M	349M	336M
Buildings, Total	259M	400M	496M	527M	540M
Machinery, Total	518M	849M	967M	1.17B	1.22B
Full Time Employees	1.59K	1.89K	1.94K	1.98K	1.66K
Accumulated Allowance for Doubtful Accounts (Supple)	7.26M	8.67M	8.13M	7.94M	9.02M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	140M	155M	66.9M	39.88M	-63.47M
Depreciation & Amortization - CF	62.16M	70.67M	111M	135M	142M
Amortization of Goodwill and Intangible Assets - (CF)	1.54M	1.56M	1.56M	1.63M	1.43M
Depreciation & Amortization, Total	63.7M	72.23M	113M	137M	143M
Amortization of Deferred Charges, Total - (CF)	8.96M	5.85M	4.66M	6.1M	6.62M
(Gain) Loss From Sale Of Asset	-	-46.8K	-152K	-	-628K
(Gain) Loss on Sale of Investments - (CF)	-407K	-101K	364K	-94.57K	-185K
Asset Writedown & Restructuring Costs	228K	326K	148K	433K	16.78M
Provision and Write-off of Bad Debts	487K	2.56M	-728K	139K	1.17M
Other Operating Activities, Total	6.17M	36.84M	59.4M	29.82M	56.86M
Change In Accounts Receivable	-239M	-53.67M	-11.95M	27.13M	-55.84M
Change In Inventories	-37.38M	-133M	20.92M	-9.53M	26.28M
Change In Accounts Payable	267M	49.69M	-81.62M	-18.97M	-21.76M
Change In Deferred Taxes	3.03M	-1.62M	1.87M	-260K	-4.57M
Change in Other Net Operating Assets	-6.7M	-	-	-	-
Cash from Operations	206M	135M	173M	211M	104M
Capital Expenditure	-376M	-252M	-175M	-81.25M	-17.96M
Sale of Property, Plant, and Equipment	-	70K	-	-	-
Investment in Marketable and Equity Securities, Total	44.43M	126K	-	-1	-12
Other Investing Activities, Total	-	-	-	81.1K	198K
Cash from Investing	-332M	-252M	-175M	-81.17M	-17.77M
Long-Term Debt Issued, Total	286M	234M	193M	53.89M	212M
Total Debt Issued	286M	234M	193M	53.89M	212M
Long-Term Debt Repaid, Total	-76.33M	-57.69M	-90.36M	-127M	-153M
Total Debt Repaid	-76.33M	-57.69M	-90.36M	-127M	-153M
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-1.66M	-13.86M	-	-	-
Common Dividends Paid	-82.65M	-89.68M	-102M	-84.7M	-64.09M
Common & Preferred Stock Dividends Paid	-82.65M	-89.68M	-102M	-84.7M	-64.09M
Other Financing Activities, Total	29.65M	-	-5.17M	0	-54.21M
Cash from Financing	155M	73.2M	-4.48M	-158M	-60.02M
Foreign Exchange Rate Adjustments	-590K	1.37M	404K	2.43M	379K
Net Change in Cash	28.27M	-41.98M	-5.93M	-25.3M	26.99M
Supplemental Items
Cash Interest Paid	-	-	-	-	-
Cash Income Tax Paid (Refund)	76.66M	81.25M	40.08M	77.33M	81.34M
Levered Free Cash Flow	-207M	-129M	-134M	126M	110M
Unlevered Free Cash Flow	-206M	-125M	-124M	136M	118M
Change In Net Working Capital	-18.06M	54.97M	113M	-49.66M	-3.09M
Net Debt Issued / Repaid	210M	177M	103M	-73.05M	58.27M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	5.06	4.95	2	1.12	-0.79
Return on Total Capital	6.91	6.77	2.65	1.45	-1.03
Return On Equity %	13	13.47	5.63	3.42	-5.8
Return on Common Equity	13	13.47	5.63	3.42	-5.8
Margin Analysis
Gross Profit Margin %	59.76	53.63	46.97	41.48	35
SG&A Margin	39.99	33.5	30.38	26.25	28.23
EBITDA Margin %	16.67	17.16	14.18	14.66	9.74
EBITA Margin %	11.77	12.21	5.72	3.48	-2.14
EBIT Margin %	11.64	12.1	5.6	3.34	-2.26
Income From Continuing Operations Margin %	11.75	11.33	5.18	3.37	-5.4
Net Income Margin %	11.75	11.33	5.18	3.37	-5.4
Net Avail. For Common Margin %	11.75	11.33	5.18	3.37	-5.4
Normalized Net Income Margin	7.19	7.35	2.86	1.37	-2.31
Levered Free Cash Flow Margin	-17.4	-9.42	-10.41	10.65	9.36
Unlevered Free Cash Flow Margin	-17.31	-9.1	-9.63	11.48	10.06
Asset Turnover
Asset Turnover	0.7	0.65	0.57	0.53	0.56
Fixed Assets Turnover	1.53	1.25	1.04	0.96	1.03
Receivables Turnover (Average Receivables)	7.46	7.53	6.19	5.53	5.63
Inventory Turnover (Average Inventory)	1.5	1.64	1.6	1.61	1.83
Short Term Liquidity
Current Ratio	1.91	1.6	1.94	1.69	1.6
Quick Ratio	0.98	0.82	0.96	0.81	0.85
Operating Cash Flow to Current Liabilities	0.49	0.23	0.39	0.4	0.19
Days Sales Outstanding (Average Receivables)	48.94	48.5	59	66.17	64.82
Days Outstanding Inventory (Average Inventory)	242.98	222.67	228.13	226.79	199.69
Average Days Payable Outstanding	86.85	90.04	101.6	96.07	93.36
Cash Conversion Cycle (Average Days)	205.07	181.13	185.54	196.9	171.15
Long Term Solvency
Total Debt/Equity	25.77	39.17	48.58	43.45	51.26
Total Debt / Total Capital	20.49	28.14	32.7	30.29	33.89
LT Debt/Equity	22.58	31.64	37.43	31.87	30.01
Long-Term Debt / Total Capital	17.95	22.74	25.19	22.22	19.84
Total Liabilities / Total Assets	41.75	47.69	47.07	47.48	48.81
EBIT / Interest Expense	78.15	23.83	4.49	2.5	-2.03
EBITDA / Interest Expense	114.1	34.2	11.49	11.16	8.89
(EBITDA - Capex) / Interest Expense	-98.36	-1.94	0.66	6.01	7.52
Total Debt / EBITDA	1.42	1.97	3.09	2.84	4.57
Net Debt / EBITDA	0.18	1.04	1.94	1.67	2.37
Total Debt / (EBITDA - Capex)	-1.64	-34.68	53.81	5.28	5.4
Net Debt / (EBITDA - Capex)	-0.21	-18.31	33.71	3.1	2.8
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-5.01	15.32	-5.86	-8.48	-0.51
Gross Profit, 1 Yr. Growth %	-6.54	3.49	-17.54	-19.18	-16.05
EBITDA, 1 Yr. Growth %	-2.52	18.68	-22.2	-4.93	-33.67
EBITA, 1 Yr. Growth %	-9.58	19.68	-55.92	-43.62	-161.86
EBIT, 1 Yr. Growth %	-9.81	19.88	-56.44	-44.67	-168.1
Earnings From Cont. Operations, 1 Yr. Growth %	2.87	11.24	-56.97	-40.38	-259.14
Net Income, 1 Yr. Growth %	2.87	11.24	-56.97	-40.38	-259.14
Normalized Net Income, 1 Yr. Growth %	-9.44	17.93	-63.39	-55.9	-270.63
Diluted EPS Before Extra, 1 Yr. Growth %	2.71	12.07	-56.52	-40	-258.33
Accounts Receivable, 1 Yr. Growth %	0.9	26.44	4.84	0.61	-7.23
Inventory, 1 Yr. Growth %	11.1	31.39	-5.76	6.39	-10.72
Net Property, Plant and Equip., 1 Yr. Growth %	67.11	25.82	2.12	-3.26	-10.48
Total Assets, 1 Yr. Growth %	26.14	19.74	-2.59	-1.53	-7.52
Tangible Book Value, 1 Yr. Growth %	7.24	8.17	-1.35	-2.28	-10.32
Common Equity, 1 Yr. Growth %	7.12	7.54	-1.41	-2.29	-9.87
Cash From Operations, 1 Yr. Growth %	-17.75	-34.43	27.9	22.3	-50.56
Capital Expenditures, 1 Yr. Growth %	46.64	-33.13	-30.67	-53.45	-77.89
Levered Free Cash Flow, 1 Yr. Growth %	114.42	-37.57	4.06	-193.22	-12.31
Unlevered Free Cash Flow, 1 Yr. Growth %	115.74	-39.35	-0.38	-208.62	-12.65
Dividend Per Share, 1 Yr. Growth %	0	13.74	-20	-25	-
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-6.46	4.67	4.2	-7.18	-4.58
Gross Profit, 2 Yr. CAGR %	-14.4	-1.65	-7.62	-18.36	-17.63
EBITDA, 2 Yr. CAGR %	20.82	7.56	-3.91	-14.21	-20.7
EBITA, 2 Yr. CAGR %	18.78	4.02	-27.37	-50.45	-41.31
EBIT, 2 Yr. CAGR %	18.69	3.98	-27.74	-51.21	-39.01
Earnings From Cont. Operations, 2 Yr. CAGR %	8.42	6.98	-30.82	-49.35	-2.59
Net Income, 2 Yr. CAGR %	8.42	6.98	-30.82	-49.35	-2.59
Normalized Net Income, 2 Yr. CAGR %	13.69	3.34	-34.29	-59.88	-14.11
Diluted EPS Before Extra, 2 Yr. CAGR %	8.98	6.86	-30.52	-48.92	-2.53
Accounts Receivable, 2 Yr. CAGR %	-8.14	12.95	15.14	2.71	-3.39
Inventory, 2 Yr. CAGR %	18.32	20.82	11.28	0.13	-2.54
Net Property, Plant and Equip., 2 Yr. CAGR %	48.6	45	13.35	-0.61	-6.94
Total Assets, 2 Yr. CAGR %	19.97	22.9	8.01	-2.06	-4.58
Tangible Book Value, 2 Yr. CAGR %	8.25	7.7	3.3	-1.82	-6.39
Common Equity, 2 Yr. CAGR %	8.76	7.33	2.97	-1.85	-6.16
Cash From Operations, 2 Yr. CAGR %	16.66	-26.56	-8.42	25.07	-22.24
Capital Expenditures, 2 Yr. CAGR %	25.24	-0.98	-31.91	-43.19	-67.92
Levered Free Cash Flow, 2 Yr. CAGR %	43.97	15.7	-19.4	-1.31	-9.7
Unlevered Free Cash Flow, 2 Yr. CAGR %	44.49	14.39	-22.27	4.26	-2.71
Dividend Per Share, 2 Yr. CAGR %	0	6.65	-4.61	-22.54	-
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	4.46	0.3	1.03	-0.21	-5
Gross Profit, 3 Yr. CAGR %	-3.13	-8.81	-7.26	-11.65	-17.6
EBITDA, 3 Yr. CAGR %	11.51	20.1	-3.45	-4.41	-21.33
EBITA, 3 Yr. CAGR %	7.66	19.08	-21.86	-33.52	-46.87
EBIT, 3 Yr. CAGR %	7.44	19.09	-22.2	-34.16	-45.71
Earnings From Cont. Operations, 3 Yr. CAGR %	9.37	9.35	-21.03	-34.16	-25.82
Net Income, 3 Yr. CAGR %	9.37	9.35	-21.03	-34.16	-25.82
Normalized Net Income, 3 Yr. CAGR %	4.3	15.08	-26.87	-42.53	-35.42
Diluted EPS Before Extra, 3 Yr. CAGR %	8.81	9.71	-21.06	-33.84	-25.53
Accounts Receivable, 3 Yr. CAGR %	7.42	2.18	10.18	10.08	-0.72
Inventory, 3 Yr. CAGR %	25.16	22.53	11.22	9.62	-3.63
Net Property, Plant and Equip., 3 Yr. CAGR %	46.49	40.58	29.01	7.52	-4.01
Total Assets, 3 Yr. CAGR %	18.81	19.89	13.75	4.73	-3.92
Tangible Book Value, 3 Yr. CAGR %	7.12	8.22	4.59	1.4	-4.74
Common Equity, 3 Yr. CAGR %	8.48	8.35	4.33	1.18	-4.6
Cash From Operations, 3 Yr. CAGR %	8.99	-3.73	-11.64	0.85	-8.21
Capital Expenditures, 3 Yr. CAGR %	48.35	1.6	-12.07	-40.02	-58.52
Levered Free Cash Flow, 3 Yr. CAGR %	90.3	8.97	11.68	-15.28	-5.2
Unlevered Free Cash Flow, 3 Yr. CAGR %	94.23	8.18	9.24	-12.97	-1.79
Dividend Per Share, 3 Yr. CAGR %	0	4.38	-3.1	-11.96	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	12.79	11.98	4.36	-2.76	-1.25
Gross Profit, 5 Yr. CAGR %	11.28	7.88	-4.95	-12.76	-11.56
EBITDA, 5 Yr. CAGR %	12.83	12.5	5.07	4.98	-10.85
EBITA, 5 Yr. CAGR %	9.47	10.74	-8.02	-16.14	-30.48
EBIT, 5 Yr. CAGR %	9.37	10.66	-8.32	-16.66	-29.59
Earnings From Cont. Operations, 5 Yr. CAGR %	9.83	11.39	-8.94	-19.62	-14.12
Net Income, 5 Yr. CAGR %	9.83	11.39	-8.94	-19.62	-14.12
Normalized Net Income, 5 Yr. CAGR %	9.81	11.72	-13.3	-24.5	-22.06
Diluted EPS Before Extra, 5 Yr. CAGR %	3.18	4.65	-9.21	-19.35	-14.12
Accounts Receivable, 5 Yr. CAGR %	13.56	14.67	10.44	2.39	4.54
Inventory, 5 Yr. CAGR %	32.18	29.12	19.41	13.02	5.5
Net Property, Plant and Equip., 5 Yr. CAGR %	30.94	37.56	32.21	22.38	13.21
Total Assets, 5 Yr. CAGR %	25.37	26.49	14.37	10.58	6.03
Tangible Book Value, 5 Yr. CAGR %	22.75	19.37	5.58	4.09	0.05
Common Equity, 5 Yr. CAGR %	22.8	19.59	6.24	4.15	0
Cash From Operations, 5 Yr. CAGR %	16.96	8.54	1.66	6.9	-16.05
Capital Expenditures, 5 Yr. CAGR %	42.59	47.23	8.64	-19.48	-41.25
Levered Free Cash Flow, 5 Yr. CAGR %	85.43	76.87	34.96	4.74	2.66
Unlevered Free Cash Flow, 5 Yr. CAGR %	96.7	96.42	34.66	6.6	4.39
Dividend Per Share, 5 Yr. CAGR %	-	3.19	-1.87	-7.36	-